Norton Leatherman Spine Surgeon Makes History With First in World Use of New Spine Surgery Robot

April 21, 2026 1:25 PM

Norton Leatherman Spine has reached a major milestone in the evolution of spine care.Jeffrey L. Gum, M.D., spine surgeon with Norton Leatherman Spine, has become the first in the world to perform spine surgery using a next-generation robotic-assisted platform designed to deliver greater precision and accuracy than any previous technology. Dr. Gum played a critical role in its development, contributing to both design and readiness for clinical...

Read more

3Aware Launches Evidence Vault to Help Health Systems Turn Clinical Data into Scalable Research and Revenue

April 21, 2026 1:00 PM

3Aware announced the launch of the Evidence Vault - a new, federated clinical research and commercialization infrastructure that enables health systems to participate as Commercial Data Partners while maintaining full control of their data, governance, and exports.The network of vaults, powered by 3Aware, is designed for health systems that want to expand investigator-led research, collaborate selectively, and support industry-sponsored studies...

Read more

Justera Announces CFO Appointments

April 21, 2026 1:00 PM

Justera Health Inc. (CSE:VTAL)(OTC:SCRSF) ("Justera" or the "Company") is pleased to announce the appointment of Bruce (Hwan) Lee as Chief Financial Officer of the Company, effective April 21, 2026.The Company notes that Mr. Lee has been appointed to fill the vacancy created by the resignation of former CFO Paul Haber on March 2, 2026. Mr. Lee's appointment is expected to further strengthen the Company's financial leadership, and reporting and...

Read more

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

April 21, 2026 12:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the U.S. introduction of the "18 Series" - a premium nutraceutical platform designed to meet growing consumer demand for clinically validated health solutions. 1. The 18 Series - OverviewCosmos Health Inc. is executing a disciplined, science-first strategy to build the what we believe to be most...

Read more

MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography

April 21, 2026 11:00 AM

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materialsDrop-in replacements preserve established chromatography performanceSupports progress toward sustainability targets by lowering product-related greenhouse gas emissionsMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of the first bio-based...

Read more

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

April 21, 2026 10:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 - June 2 in Chicago, IL.The presentation details are as follows:Oral Presentation:Abstract #9500: Individualized neoantigen therapy intismeran autogene (intismeran) plus pembrolizumab (pembro) in resected...

Read more

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

April 21, 2026 9:40 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX® (mRNA-1083), the Company's mRNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older.This marketing authorization follows the positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal...

Read more

NCQA and West Health Partner to Advance Integration of Behavioral Health into Primary Care

April 21, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) and West Health announced a strategic partnership to advance the integration of behavioral health into primary care, where most patients first seek help, enabling earlier identification, diagnosis and treatment of mental health conditions that might otherwise go unaddressed, untreated or misidentified.The multi-year initiative combines NCQA's leadership in healthcare quality measurement with...

Read more

Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides

April 21, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, comments that its drug candidate NV-387 is the weapon necessary for combatting growing cases of deadly measles worldwide.Bangladesh recently reported 18,219 suspected measles cases, including 2,897...

Read more

Esco Lifesciences Group Announces Acquisition of Allwin Medical

April 21, 2026 8:30 AM

Esco Lifesciences Group ("Esco") today announced the acquisition of Allwin Medical Devices, Inc., a leading manufacturer of ART/IVF consumables. Allwin Medical will continue to operate under its established brand and will become a key pillar within Esco's Medical portfolio, alongside Esco Medical, further strengthening Esco's global position in reproductive medicine.The acquisition reinforces Esco's strategy and commitment to deliver integrated...

Read more

AMC Health Deepens Its Role as the Trusted Operational Partner for Decentralized Clinical Trials with the Appointment of Keith Tode as EVP

April 21, 2026 8:00 AM

AMC Health, a leader in remote patient monitoring and decentralized clinical trial services, today announced the appointment of Keith Tode as Executive Vice President of Decentralized Clinical Trials. The appointment reflects growing demand from biopharmaceutical and pharmaceutical sponsors, medical device companies, and contract research organizations (CROs) seeking an operational partner with the scale, infrastructure, and regulatory rigor...

Read more

CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Patches 

April 21, 2026 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the launch of our New CBD Patches. CBD Patch is a transdermal patch infused with 100 MG of Broad Spectrum Nano CBD. This provides up to 96 hours of extended relief. This patch is Hypoallergenic and Latex. The benefits include long lasting pain relief, muscle recovery, inflammation relief, anxiety relief and calming purposes. This product is NON GMO, THC Free...

Read more

Moderna to Present at Upcoming Conferences in May 2026

April 21, 2026 7:00 AM

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:BofA Securities 2026 Healthcare Conference, on Tuesday, May 12th at 11:20am PTRBC 2026 Global Healthcare Conference, on Tuesday, May 19th at 10:00 am ETBernstein's 42nd Annual Strategic Decisions Conference, Thursday, May 28th at 10:00am ETA live webcast of each of these presentations will be available under "Events and Presentations" in...

Read more

Norse Organics Reaches 500,000 Customers with Its Arctic Botanical Acne System, Expanding Global Availability Across Four Continents

April 21, 2026 6:35 AM

Norse Organics, the Norwegian botanical skincare company founded on the principle that wild-harvested Arctic plants outperform synthetic chemistry, today announced the global expansion of its flagship three-product acne system following a milestone of 500,000 customers served. The Kill Acne & Redness Ritual is now available in the United States, Canada, the European Union, the United Kingdom, and Australia, with the company reporting a 97%...

Read more

Integrated Case Management Services to Close Gaps in Patient Care

April 21, 2026 6:00 AM

Bionic Bloom Wellness Collective and the Neurodivergent Empowerment Institute (NEI), founded by Angela Fisher, today announced the launch of a comprehensive Case Management program designed to bridge the gaps between medical, mental health, and supportive services.The new program establishes a continuous layer of care coordination for patients navigating complex needs, ensuring that treatment plans are not only created-but followed through with...

Read more

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders

April 20, 2026 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Special Meeting of Stockholders held on April 20, 2026 (the "Special Meeting").Five proposals were submitted to and approved by the stockholders of the Company at the Special Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the...

Read more

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

April 20, 2026 10:55 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided a commercial and financial update on Liv18™, its clinically validated liver health supplement, as the Company accelerates its expansion across the United States.The Company has successfully completed Phase 1 execution for Liv18™ (defined as product development, packaging, and initial commercial setup)...

Read more

Black Book's 2026 Healthcare Autonomy Report Identifies Innovaccer as Current Leader in Emerging AI Category

April 20, 2026 10:45 AM

Black Book Market Research today released its new report, Healthcare Autonomy: The Next AI Category, a Q2 2026 analysis of ROI maturity, operational readiness, and the competitive landscape for healthcare AI platforms designed to move beyond insight generation into coordinated workflow execution.The report is based on a structured survey of 340 healthcare organizations actively adopting AI across provider operations, revenue cycle, digital...

Read more

Snapshot Recipes AI Mobile App Celebrates Approved Feature-Rich Update and AI Marketing Expansion

April 20, 2026 9:17 AM

Medical Care Technologies (OTC Pink:MDCE) is excited to share that our latest version of Snapshot Recipes (Build 134) has been approved by both the Google Play Store and the Apple App Store. This new build is fully optimized, offering a seamless user experience, streamlined subscription processes, and the most comprehensive recipe features yet. Users can now create recipes with limitless creativity by typing a name, snapping a photo of...

Read more

MMJ International Holdings Joins Federal Lawsuit on 4/20 to Stop CMS From Introducing Unvalidated Cannabinoid Products Into America's 65+ Population

April 20, 2026 9:15 AM

On a day traditionally associated with cannabis advocacy, MMJ International Holdings announced its support for litigation aligned with Smart Approaches to Marijuana et al challenging the Centers for Medicare & Medicaid Services' cannabinoid reimbursement framework, warning that federal healthcare dollars should not be used to introduce unvalidated botanical products into the Medicare population. The company's position is clear:Botanical...

Read more